Skip to main content
logo
Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
2.020
-0.260 (-11.40%)
May 18, 2026, 4:00 PM EDT - Market closed

Pyxis Oncology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
13.8613.8616.15---
Revenue Growth (YoY)
--14.17%----
Cost of Revenue
2.392.390.48---
Gross Profit
11.4711.4715.67---
Selling, General & Admin
20.722.1925.4232.6137.3518.66
Research & Development
76.6473.758.7549.5986.1351.05
Other Operating Expenses
--20.96---
Total Operating Expenses
97.3495.89105.1382.2123.4869.72
Operating Income
-85.87-84.42-89.46-82.2-123.48-69.72
Interest Income
2.833.617.046.632.760.25
Other Non-Operating Income (Expense)
5.526.199.978.412.76-6.03
Total Non-Operating Income (Expense)
8.349.81715.045.53-5.77
Pretax Income
-79.89-78.24-79.5-73.79-117.95-75.49
Provision for Income Taxes
0.28-1.392.16---
Net Income
-81.74-79.62-77.33-73.79-120.72-75.98
Net Income to Common
-81.74-79.62-77.33-73.79-120.72-75.98
Shares Outstanding (Basic)
63625840338
Shares Outstanding (Diluted)
63625840338
Shares Change (YoY)
3.07%6.33%46.46%20.80%288.93%724.14%
EPS (Basic)
-1.31-1.28-1.32-1.85-3.65-8.95
EPS (Diluted)
-1.31-1.28-1.32-1.85-3.65-8.95
Shares Outstanding
62.8362.6959.9744.7534.9632.22
Free Cash Flow
-66.98-63.51-57.91-77.44-95.73-35.87
Free Cash Flow Per Share
-1.07-1.02-0.99-1.94-2.90-4.22
Gross Margin
82.77%82.77%97.06%---
Operating Margin
-619.61%-609.18%-554.07%---
Profit Margin
-578.55%-554.55%-505.75%---
FCF Margin
-483.30%-458.30%-358.66%---
EBITDA
-81.45-79.91-86.48-80.27-122.77-69.07
EBITDA Margin
-587.73%-576.63%-535.60%---
EBIT
-85.87-84.42-89.46-82.2-123.48-69.72
EBIT Margin
-619.61%-609.18%-554.07%---
Effective Tax Rate
-0.35%1.77%-2.72%0.00%0.00%0.00%
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q